Psyllium Plantago ovata Forssk.
Also called: psyllium husk, psyllium seed husk, ispaghula, blond psyllium, Indian psyllium
The dried seed coat (husk) of Plantago ovata seeds, a source of soluble fiber. It is used as a bulk-forming laxative and as a food ingredient, and qualifies for an FDA-authorized heart-disease health claim.
- Category
- Botanical
- Part used
- Seed husk (dried seed coat, epidermis)
- Strongest evidence
- A Strong
- Reviewed
- 2026-10-28
Class 1 Well studied in people. A 2018 meta-analysis (Am J Clin Nutr) pooled 28 RCTs (1,924 participants; median dose about 10.2 g, for at least 3 weeks) of psyllium on blood lipids; its full text, needed to confirm that no trial combined psyllium with other agents, was not available. [4]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
AHeart and blood vessels2 topics
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| LDL cholesterol in adults with or without high cholesterol | A | Meta-analysis of 28 randomized trials (1,924 participants; median dose ~10.2 g; at least 3 weeks): LDL cholesterol fell by 0.33 mmol/L (95% CI −0.38 to −0.27) versus control; certainty rated moderate. [4] |
| Non-HDL cholesterol and apolipoprotein B | A | Same meta-analysis: non-HDL cholesterol fell by 0.39 mmol/L (95% CI −0.50 to −0.27) and apoB by 0.05 g/L (95% CI −0.08 to −0.03); certainty moderate and high. [4] |
Main constituents: Soluble fiber (psyllium seed husk) [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- FDA health claim: 7 g or more per day of soluble fiber from psyllium seed husk; a qualifying food provides at least 1.7 g soluble fiber per reference amount. [1]
- As a laxative: mix powder or granules with 8 ounces (240 mL) of liquid and drink at least 8 ounces of liquid with each dose; do not use for more than 1 week unless a doctor directs. [3]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingEU monograph: limited data (fewer than 300 pregnancy outcomes) …
1 statement in the profile.
Details and sources - Interactions with medicines4 listed
Minerals, vitamin B12, cardiac glycosides, coumarin derivatives, carbamazepine, lithium; Antidiabetic therapy; Thyroid hormones …
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications2 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsStated
EU (EMA HMPC monograph, 14 May 2013), well-established use: adolescents, adults and elderly 7-11 g daily in 1-3 doses (constipation and soft-stool …
Details and sources
- Psyllium foods carrying the health claim must warn that the product should be eaten with at least a full glass of liquid, that eating it without enough liquid may cause choking, and that people with difficulty swallowing should not eat it. [2]
- Call a doctor immediately for difficulty breathing, difficulty swallowing, stomach pain, skin rash, itching, nausea or vomiting. [3]
Interactions
| With | What happens |
|---|---|
| Digoxin, salicylates (aspirin), nitrofurantoin | Do not take these within 3 hours of taking psyllium. [3] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- For the FDA claim, psyllium husk must be at least 95% pure: 3% or less protein, 4.5% or less light and 0.5% or less heavy extraneous matter, combined extraneous matter not over 4.9%, by USP methods. [1]
Regulatory status
- US: FDA authorizes a health claim (21 CFR 101.81): soluble fiber from foods such as psyllium husk, as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease; the label states grams supplied per serving. [1]
- US: foods with dry or incompletely hydrated psyllium husk that carry this claim must show a 'NOTICE' about adequate fluid and choking risk (21 CFR 101.17(f)). [2]
- US: psyllium is also a bulk-forming laxative medicine for constipation. [3]
- EU: ispaghula husk has a European Union herbal monograph based on well-established use for habitual constipation, conditions needing softer stools, and increasing fiber intake (including in hypercholesterolemia with diet, under medical supervision). [5]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Mucilage of the seed husk: polysaccharides with a beta-linked xylan backbone and side chains, only partially solubilized Polysaccharides (soluble fiber) [P5]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 2 entries naming psyllium (Plantago ovata) (earliest NDI 361 submitted 2005-11-14; most recent NDI 411 submitted 2006-08-16). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P1]
- 21 CFR 101.81 authorizes a health claim for soluble fiber from psyllium husk and coronary heart disease risk, for foods meeting its conditions. [P6]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- Minerals, vitamin B12, cardiac glycosides, coumarin derivatives, carbamazepine, lithium: EU monograph: enteral absorption of concomitantly administered medicines may be delayed; the product should not be taken 1/2 to 1 hour before or after other medicinal products. [P5]
- Antidiabetic therapy: EU monograph: diabetic patients should take ispaghula husk only under medical supervision because adjustment of anti-diabetic therapy may be necessary. [P5]
- Thyroid hormones: EU monograph: concomitant use requires medical supervision because the thyroid hormone dose may have to be adjusted. [P5]
- Digoxin, salicylates (aspirin), nitrofurantoin: MedlinePlus: do not take these within 3 hours of taking psyllium. [P7]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of each dietary-ingredient component — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants a petition-based exemption under 111.75(a)(1)(ii). [P4]
- Purity: at least 95% pure; 3% or less protein, 4.5% or less light and 0.5% or less heavy extraneous matter (combined not over 4.9%), by USP-NF methods — 21 CFR 101.81(c)(2)(ii)(B)(1) sets this purity for psyllium husk eligible for the soluble-fiber health claim. [P6]
- Compliance with the European Pharmacopoeia monograph (ref. 01/2008:1334) — The EU herbal monograph states the material complies with this Ph. Eur. monograph. [P5]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- EU monograph: the husk hydrates and swells to form a mucilage; its beta-linked sugar residues cannot be broken by human digestive enzymes. Less than 10% of the mucilage is hydrolyzed in the stomach, forming free arabinose, of which about 85% to 93% is absorbed; the remainder reaches the colon, where it is fermented to a limited extent. [P5]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- EU (EMA HMPC monograph, 14 May 2013), well-established use: adolescents, adults and elderly 7-11 g daily in 1-3 doses (constipation and soft-stool indications) or 7-20 g daily in 1-3 doses (increased fiber intake indication); children 6-12 years 3-8 g daily for the first two indications; taken with sufficient liquid, e.g. 30 ml water per 1 g. [P5]
Pregnancy and breastfeeding
- EU monograph: limited data (fewer than 300 pregnancy outcomes); use may be considered during pregnancy and lactation if necessary and if change of nutrition is not successful. [P5]
Sources for this profile
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (list last updated 2026-07-23 per page data; checked 2026-10-29), 2026-07-23. monographs.iarc.who.int
- National Toxicology Program (NIEHS). Technical Reports list (checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- European Medicines Agency, HMPC. Community herbal monograph on Plantago ovata Forssk., seminis tegumentum, EMA/HMPC/199774/2012 (final, 14 May 2013), 2013-05-14. ema.europa.eu
- eCFR. 21 CFR 101.81, Health claims: Soluble fiber from certain foods and risk of coronary heart disease (up to date as of 8/06/2026), 2026-08-06. ecfr.gov
- MedlinePlus (U.S. National Library of Medicine). Psyllium (Last Revised 06/20/2024), 2024-06-20. medlineplus.gov
Sources
- eCFR. 21 CFR 101.81, Health claims: Soluble fiber from certain foods and risk of coronary heart disease (up to date as of 8/06/2026), 2026-08-06. ecfr.gov
- eCFR. 21 CFR 101.17, Food labeling warning, notice, and safe handling statements, paragraph (f) (up to date as of 10/22/2026), 2026-10-22. ecfr.gov
- MedlinePlus (U.S. National Library of Medicine). Psyllium (last revised June 20, 2024), 2024-06-20. medlineplus.gov
- Jovanovski E, Yashpal S, Komishon A, et al. Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 2018;108(5):922-932 (PMID 30239559), 2018-11-01. pubmed.ncbi.nlm.nih.gov
- European Medicines Agency. Plantaginis ovatae seminis tegumentum: herbal medicinal product (monograph Rev. 1, 23/07/2013), 2013-07-23. ema.europa.eu
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.